Preprint · OA
via OpenAlex
Impact of stress exposure and pharmacological intervention on a mouse model of Alzheimer’s disease
Research Publications (Maastricht University) · 2012
Abstract
In this dissertation, we have made use of the APPswe/PS1ΔE9 mouse model of AD, created by Dr. David Borchelt and coworkers [47].This mouse model carries a double genetic mutation: the Swedish mutation on the APP695 isoform (K694L/N595L), which was first discovered in a Swedish family, combined with the PS1 mutation which leads to a deletion of exon 9 within that gene.Both mutations are under the expression of the mouse prion protein promotor, thereby directing expression of both transgenes mainly to CNS neurons [48].The human/mouse chimeric APP695 Swedish mutation leads to a 2-3 fold overexpression of the APP protein [48], while the PS1ΔE9 mutation causes an increase in the production of Aβ42 over Aβ40 [49], thereby leading to plaque deposition from 4 months of age [50].The first cognitive deficits are reported from 7 months of age onwards [51,52].The recapitulation of amyloid pathology and cognitive deficits as seen in AD patients, and the relative quick onset of pathology and symptoms, makes the APPswe/PS1ΔE9 mouse model a suitable model for investigating AD-related processes. Current treatment optionsAD is an incurable illness, and its treatment options are limited.Today, the only types of medication approved for the treatment of AD are acetylcholinesterase inhibitors, e.g.rivastigmine and donepezil, and one NMDA-receptor antagonist, i.e. memantine [53].
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.26481/dis.20121220ss
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
Sierksma, S. (2012). Impact of stress exposure and pharmacological intervention on a mouse model of Alzheimer’s disease. <em>Research Publications (Maastricht University)</em>. https://doi.org/10.26481/dis.20121220ss
Vancouver
Sierksma S. Impact of stress exposure and pharmacological intervention on a mouse model of Alzheimer’s disease. Research Publications (Maastricht University). 2012. doi:10.26481/dis.20121220ss.
BibTeX
@unpublished{sr2012Impact,
title = {Impact of stress exposure and pharmacological intervention on a mouse model of Alzheimer’s disease},
author = {S.R. Sierksma},
journal = {Research Publications (Maastricht University)},
year = {2012},
doi = {10.26481/dis.20121220ss},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging and Disease 2023
Open access · CC-BY
SARM1 Promotes Neurodegeneration and Memory Impairment in Mouse Models of Alzheimer's Disease
cIRcle (University of British Columbia) 2017
Preprint · CC-BY
Selective neurodegeneration in Alzheimer's disease and Parkinson's disease
Aging 2020
Preprint · CC-BY
Hippocampal and cortical tissue-specific epigenetic clocks indicate an increased epigenetic age in a mouse model for Alzheimer’s disease
Aging Cell 2019
Open access · CC-BY
The role of lipid metabolism in aging, lifespan regulation, and age‐related disease
The Journals of Gerontology Series A 2013
Open access · CC-BY
A Clinical Frailty Index in Aging Mice: Comparisons With Frailty Index Data in Humans
Biological Psychiatry Global Open Science 2025
Open access · CC-BY